In tumor patients, an increased circulation of gal-2, -4 and -8 interacts with the vascular endothelium and significantly promotes the increased circulation of granulocyte colony-stimulating factor (G-CSF), IL-6 and monocyte chemoattractant protein-1 (MCP-1). The gene discussed is CCL2; the disease is neoplasm.